Copayments for Medications in 2015. Final rule.

Area of Science:

• Health Policy and Regulation
• Veterans Affairs Healthcare
• Pharmaceutical Economics

Background:

• The Department of Veterans Affairs (VA) previously implemented an interim final rule to freeze medication copayments.
• This freeze was set to maintain 2014 copayment rates and was scheduled to expire on January 1, 2016.
• The copayment amounts were $8 for veterans in priority groups 2-6 and $9 for veterans in priority groups 7 and 8.

Purpose of the Study:

• To adopt a final rule extending the freeze on specific medication copayments provided by the VA.
• To prevent an increase in copayment costs for veterans that would have occurred based on the Medical Consumer Price Index (CPI-P).
• To provide continued financial relief to veterans regarding prescription medication costs.

Main Methods:

• Adoption of a final rule amending existing Department of Veterans Affairs (VA) medical regulations.
• Extension of the previously established copayment freeze for certain medications.
• Maintaining the 2014 copayment rates for veterans in specified priority groups.

Main Results:

• The final rule officially extends the copayment freeze for certain VA-provided medications through December 31, 2016.
• Veterans will continue to pay the 2014 copayment rates ($8 or $9 depending on priority group) through the extended period.
• The rule prevents the planned increase in copayments that was indexed to the Medical Consumer Price Index (CPI-P).

Conclusions:

• The extension of the copayment freeze provides continued financial stability for veterans utilizing VA pharmacy services.
• This regulatory action underscores the VA's commitment to managing healthcare costs for its beneficiaries.
• The policy aims to mitigate the impact of rising prescription drug costs on veterans' healthcare expenses.